---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-081155"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T18:56:51.782927+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma appoints KPMG as new independent auditor, replacing Ernst & Young

## Summary
- On July 16, 2024, Traws Pharma's Audit Committee engaged KPMG as its new independent registered public accounting firm for the year ending December 31, 2024.
- During the fiscal years 2022 and 2023 and interim period through July 16, 2024, the company did not consult KPMG on accounting principles or any disagreements/reportable events.
- Ernst & Young provided a letter to the SEC dated July 19, 2024, agreeing with the company's statements regarding the auditor change.

## SEC filing metadata
- accession: 0001104659-24-081155
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465924081155/0001104659-24-081155-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465924081155/tm2419807d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-081155
- JSON: https://secwatch.observer/filing/0001104659-24-081155.json
- Plain text: https://secwatch.observer/filing/0001104659-24-081155.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.